Deerfield, IL - Baxter International is now recalling from the market all remaining lots and doses of its heparin sodium multidose and single-dose vials for injection and its heparin lock flush ...
Taurolidine is an antibacterial and antifungal agent with a mechanism of action that is less prone to development of antimicrobial resistance. A taurolidine/heparin lock solution carries a lower risk ...
Review the side-effects of Preservative-Free Heparin Lock Flush Solution as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking ...
SCHAUMBURG, Ill.--(BUSINESS WIRE)--APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc. (NASDAQ:APCVZ), announced today that it has received clearance ...
Up-to-date prescription details regarding Preservative-Free Heparin Lock Flush Solution are provided here. Understand it's uses, recommended dosages, its indications, how to take, when to take, when ...
Use of high-dose (46.7%) sodium citrate locks for central venous catheters (CVCs) being used for maintenance hemodialysis provides no advantage over 5% heparin locks in reducing infections or ...
A study published in Clinical Infectious Diseases examined the cost-effectiveness of antimicrobial locks for the prevention of central line-associated bloodstream infections. Antibiotic lock therapy ...
Mar. 24 -- THURSDAY, Feb. 28 (HealthDay News) -- Baxter Healthcare Corp., the pharmaceutical company at the center of recent problems with its blood thinner heparin, announced Thursday that it was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results